Cardiovascular and gastrointestinal events of three antiplatelet therapies: Clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding

Journal of Gastroenterology

Volumn 46, Issue 1, 2011, Pages 39-45

  Tsai, Yi Wen ^a,b   Wen, Yu Wen ^c   Huang, Weng Foung ^b   Chen, Pei Fen ^a   Kuo, Ken N ^a   Hsiao, Fei Yuan ^d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Cardiovascular events; Clopidogrel; Gastrointestinal bleeding; Proton pump inhibitors (PPIs)

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; SEROTONIN UPTAKE INHIBITOR;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIGESTIVE SYSTEM ULCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; STROKE; SURVIVAL; TAIWAN; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIC ULCER; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK; TAIWAN; TICLOPIDINE; TREATMENT OUTCOME;

EID: 78651499946     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0299-0     Document Type: Article

References (18)

1. MA Munger DW Hawkins 2003 Atherothrombosis: epidemiology, pathophysiology, and prevention J Am Pharm Assoc 44 S5 S12 10.1331/ 154434504322904569
2. H Tran SS Anand 2004 Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease JAMA 292 1867 1874 1:CAS:528:DC%2BD2cXoslyltr4%3D 10.1001/jama.292.15.1867 15494585
3. Antithrombotic Trialists Collaboration 2002 Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 71 86 10.1136/bmj.324. 7329.71
4. RA Harrington RC Becker M Ezekowitz TW Meade CM O'Connor DA Vorchheimer, et al. 2004 Antithrombotic therapy for coronary artery disease Chest 126 513S 548S 1:CAS:528:DC%2BD2cXptV2mtrw%3D 10.1378/chest.126.3-suppl.513S 15383483
5. JL Anderson CD Adams EM Antman CR Bridges RM Califf DE Casey Jr, et al. 2007 ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction Circulation 116 e148 e304 10.1161/CIRCULATIONAHA.107.737312 17679616
6. D Sibbing T Morath J Stegherr S Braun W Vogt M Hadamitzky, et al. 2009 Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel Thromb Haemost 101 714 719 1:CAS:528:DC%2BD1MXltVertbs%3D 19350116
7. M Gilard B Arnaud JC Cornily G Le Gal K Lacut G Le Calvez, et al. 2008 Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 256 260 1:CAS:528:DC%2BD1cXpt1Gksg%3D%3D 10.1016/j.jacc.2007.06.064 18206732
8. KA Kim PW Park SJ Hong JY Park 2008 The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance Clin Pharmacol Ther 84 236 242 1:CAS:528: DC%2BD1cXptlyktLc%3D 10.1038/clpt.2008.20 18323861
9. DS Small NA Farid CD Payne GJ Weerakkody YG Li JT Brandt, et al. 2008 Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel J Clin Pharmacol 48 475 484 1:CAS:528:DC%2BD1cXkslKntLk%3D 10.1177/0091270008315310 18303127
10. DN Juurlink T Gomes DT Ko PE Szmitko PC Austin JV Tu, et al. 2009 A population-based study of the drug interaction between proton pump inhibitors and clopidogrel CMAJ 180 713 718 19176635
11. PM Ho TM Maddox L Wang SD Fihn RL Jesse ED Peterson, et al. 2009 Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 937 944 1:CAS:528:DC%2BD1MXivFejt7g%3D 10.1001/jama.2009.261 19258584
12. Bureau of National Health Insurance. National Health Insurance in Taiwan. 2007. http://www.nhi.gov.tw/english/index.asp. Accessed 19 Dec 2009.
13. M Gent D Beaumont J Blanchard 1996 A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1329 1339 1:CAS:528:DyaK28XntlGrtL0%3D 10.1016/S0140-6736(96)09457-3
14. FK Chan JY Ching LC Hung VW Wong VK Leung NN Kung, et al. 2005 Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding N Engl J Med 352 238 244 1:CAS:528:DC%2BD2MXmslShtA%3D%3D 10.1056/NEJMoa042087 15659723
15. KC Lai KM Chu WM Hui BC Wong WK Hung CK Loo, et al. 2006 Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications Clin Gastroenterol Hepatol 4 860 865 1:CAS:528: DC%2BD28XotFarsrk%3D 10.1016/j.cgh.2006.04.019 16797240
16. H Yasuda M Yamada S Sawada Y Endo K Inoue F Asano Y Takeyama M Yoshiba 2009 Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting Intern Med 48 1725 1730 10.2169/ internalmedicine.48.2031 19797827
17. PA Gurbel WC Lau US Tantry 2008 Omeprazole-a possible new candidate influencing the antiplatelet effect of clopidogrel J Am Coll Cardiol 51 261 263 10.1016/j.jacc.2007.07.090 18206733
18. JM Siller-Matula AO Spiel IM Lang G Kreiner G Christ B Jilma 2009 Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel Am Heart J 157 148.e1 148.e5 10.1016/j.ahj.2008.09.017